Seminars in Diagnostic Pathology
Volume 25, Issue 2 , Pages 100-111 , May 2008

Pathologic examination of sentinel lymph nodes from melanoma patients

  • Richard A. Scolyer, MD, FRCPA, FRCPath

      Affiliations

    • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia
    • Corresponding Author InformationAddress reprint requests and correspondence: Richard A. Scolyer, MD, FRCPA, FRCPath, Department of Anatomical Pathology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia.
    • ,
  • Rajmohan Murali, MBBS, FRCPA

      Affiliations

    • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia
    • ,
  • Stanley W. McCarthy, MBBS, FRCPA

      Affiliations

    • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Discipline of Pathology, The University of Sydney, Sydney, NSW, Australia
    • ,
  • John F. Thompson, MD, FRACS, FACS

      Affiliations

    • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
    • Discipline of Surgery, The University of Sydney, Sydney, NSW, Australia.

References 

  1. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol. 2000;7:469–474
  2. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. [see comment] Lancet. 2005;365:687–701
  3. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg. 2001;233:250–258
  4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976–983
  5. Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg. 2000;87:484–489
  6. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg. 1995;130:654–658discussion 659-660
  7. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial (Multicenter Selective Lymphadenectomy Trial Group). Ann Surg. 1999;230:453–463discussion 463-465
  8. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759–767
  9. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255–260
  10. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol. 2001;8(suppl):44S–47S
  11. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634
  12. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  13. McCarthy WH, Shaw HM, Cascinelli N, et al. Elective lymph node dissection for melanoma: two perspectives. World J Surg. 1992;16:203–213
  14. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317
  15. Diaz LK, Hunt K, Ames F, et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol. 2003;27:385–389
  16. Scolyer RA, Thompson JF, McCarthy SW, et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. [comment] J Am Coll Surg. 2005;201:821–823author reply 823-824
  17. Klausen TL, Chakera AH, Friis E, et al. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging. 2005;25:196–202
  18. Miner TJ, Shriver CD, Flicek PR, et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol. 1999;6:75–82
  19. Nejc D, Wrzesien M, Piekarski J, et al. Sentinel node biopsy in skin melanoma patients: measurements of absorbed doses of radiation to the hands of medical staff. J Surg Oncol. 2006;93:355–361
  20. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma (An immunohistological study). Am J Surg Pathol. 1988;12:612–618
  21. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253–2260
  22. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86:617–627
  23. Baisden BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol. 2000;24:1140–1146
  24. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol. 2003;200:314–319
  25. Gietema HA, Vuylsteke RJ, de Jonge IA, et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2004;57:618–620
  26. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer. 2004;100:1683–1691
  27. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol. 2005;29:305–317
  28. Cochran AJ. Surgical pathology remains pivotal in the evaluation of ‘sentinel’ lymph nodes. Am J Surg Pathol. 1999;23:1169–1172
  29. Cochran AJ, Roberts A, Wen DR, et al. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours. Pathology. 2004;36:478–484
  30. Yee VS, Thompson JF, McKinnon JG, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol. 2005;12:429–439[Published erratum appears in Ann Surg Oncol 12:843, 2005]
  31. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655–1663
  32. van Akkooi AC, de Wilt JH, Verhoef C, et al. High positive sentinel node identification rate by EORTC melanoma group protocol (Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma). Eur J Cancer. 2006;42:372–380
  33. Caraco C, Marone U, Celentano E, et al. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14:2662–2667
  34. Roulin D, Matter M, Bady P, et al. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. Eur J Surg Oncol. 2008;34:673–679
  35. Riber-Hansen R, Sjoegren P, Hamilton-Dutoit SJ, et al. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload. Ann Surg Oncol. 2008;15:1492–1501
  36. Scolyer RA, Thompson JF, McCarthy SW. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. [comment] Cancer. 2004;101:2141–2142author reply 2142-2143
  37. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197–1202
  38. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134:381–387
  39. Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747–755
  40. Dewar DJ, Newell B, Green MA, et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004;22:3345–3349
  41. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol. 2004;122:532–539
  42. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110–2121
  43. Pearlman NW, McCarter MD, Frank M, et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006;192:878–881
  44. Debarbieux S, Duru G, Dalle S, et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol. 2007;157:58–67
  45. Govindarajan A, Ghazarian DM, McCready DR, et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol. 2007;14:906–912
  46. Sabel MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg. 2005;201:37–47
  47. Murali R, Cochran AJ, Cook MG, et al. Interobserver reproducibility of the assessment of morphometric features of sentinel lymph nodes containing metastatic melanoma. Ann Surg Oncol. 2008;15(suppl 1):29–30
  48. van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol. 2006;17:1578–1585
  49. Satzger I, Volker B, Meier A, et al. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol. 2007;31:1175–1180
  50. Dawson M, Doble P, Beavis A, et al. Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst. 2003;128:217–219
  51. Scolyer RA, Thompson JF, Li LX, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol. 2004;17:1191–1197
  52. Scolyer RA, Thompson JF, Li LX, et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients. Ann Surg Oncol. 2004;11(suppl):174S–178S
  53. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538–549discussion 549-550
  54. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer. 2001;92:535–541
  55. Karim RZ, Scolyer RA, Li W, et al. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery and/or pathology. Ann Surg. 2008;247:1003–1010
  56. Giese T, Engstner M, Mansmann U, et al. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. J Invest Dermatol. 2005;124(3):633–637
  57. Blaheta HJ, Ellwanger U, Schittek B, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol. 2000;114(4):637–642
  58. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999;17(10):3238–3244
  59. Stretch JR, Somorjai R, Bourne R, et al. Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Ann Surg Oncol. 2005;12(11):943–949
  60. Beavis A, Dawson M, Doble P, et al. Sentinel lymph node identity confirmed by analysis of fine needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol. 2007;in press
  61. Starritt EC, Uren RF, Scolyer RA, et al. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol. 2005;12(1):18–23
  62. Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol. 2003;83(2):80–84
  63. Voit C, Van Akkooi AC, Schafer-Hesterberg G, et al. Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: Reduction of need for SNLB by high US-FNAC SN positive identification rate. J Clin Oncol. 2007;25(18S):8512
  64. Morton DL, Thompson JF, Cochran AJ. Sentinel-node biopsy in melanoma. N Engl J Med. 2007;356:419–421

PII: S0740-2570(08)00024-5

doi: 10.1053/j.semdp.2008.04.002

Seminars in Diagnostic Pathology
Volume 25, Issue 2 , Pages 100-111 , May 2008

Article Tools

* Image Usage & Resolution